Intestinal permeability in a patient with liver cirrhosis
- PMID: 27920543
- PMCID: PMC5125722
- DOI: 10.2147/TCRM.S115902
Intestinal permeability in a patient with liver cirrhosis
Abstract
Liver cirrhosis is a worldwide public health problem, and patients with this disease are at high risk of developing complications, bacterial translocation from the intestinal lumen to the mesenteric nodes, and systemic circulation, resulting in the development of severe complications related to high mortality rate. The intestinal barrier is a structure with a physical and biochemical activity to maintain balance between the external environment, including bacteria and their products, and the internal environment. Patients with liver cirrhosis develop a series of alterations in different components of the intestinal barrier directly associated with the severity of liver disease that finally increased intestinal permeability. A "leaky gut" is an effect produced by damaged intestinal barrier; alterations in the function of tight junction proteins are related to bacterial translocation and their products. Instead, increasing serum proinflammatory cytokines and hemodynamics modification, which results in the appearance of complications of liver cirrhosis such as hepatic encephalopathy, variceal hemorrhage, bacterial spontaneous peritonitis, and hepatorenal syndrome. The intestinal microbiota plays a fundamental role in maintaining the proper function of the intestinal barrier; bacterial overgrowth and dysbiosis are two phenomena often present in people with liver cirrhosis favoring bacterial translocation. Increased intestinal permeability has an important role in the genesis of these complications, and treating it could be the base for prevention and partial treatment of these complications.
Keywords: bacterial translocation; hepatic encephalopathy; intestinal permeability; liver cirrhosis; spontaneous bacterial peritonitis; variceal hemorrhage.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Figures

Similar articles
-
Intestinal barrier dysfunction in cirrhosis: Current concepts in pathophysiology and clinical implications.World J Hepatol. 2015 Aug 18;7(17):2058-68. doi: 10.4254/wjh.v7.i17.2058. World J Hepatol. 2015. PMID: 26301048 Free PMC article.
-
Gut microbiota-related complications in cirrhosis.World J Gastroenterol. 2014 Nov 14;20(42):15624-31. doi: 10.3748/wjg.v20.i42.15624. World J Gastroenterol. 2014. PMID: 25400446 Free PMC article. Review.
-
Liver cirrhosis and complications from the perspective of dysbiosis.Front Med (Lausanne). 2024 Jan 16;10:1320015. doi: 10.3389/fmed.2023.1320015. eCollection 2023. Front Med (Lausanne). 2024. PMID: 38293307 Free PMC article. Review.
-
FXR modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis.J Hepatol. 2019 Dec;71(6):1126-1140. doi: 10.1016/j.jhep.2019.06.017. Epub 2019 Jul 8. J Hepatol. 2019. PMID: 31295531
-
Bacterial translocation and its consequences in patients with cirrhosis.Eur J Gastroenterol Hepatol. 2005 Jan;17(1):27-31. doi: 10.1097/00042737-200501000-00006. Eur J Gastroenterol Hepatol. 2005. PMID: 15647636 Review.
Cited by
-
Management of hepatic encephalopathy following transjugular intrahepatic portosystemic shunts: Current strategies and future directions.World J Gastroenterol. 2025 Apr 21;31(15):103512. doi: 10.3748/wjg.v31.i15.103512. World J Gastroenterol. 2025. PMID: 40309228 Free PMC article. Review.
-
Serum Sphingosine-1-phosphate level and peritonitis in peritoneal dialysis patients.Ren Fail. 2020 Nov;42(1):829-835. doi: 10.1080/0886022X.2020.1805763. Ren Fail. 2020. PMID: 32787649 Free PMC article.
-
Role of endotoxemia in causing renal dysfunction in cirrhosis.J Investig Med. 2020 Jan;68(1):26-29. doi: 10.1136/jim-2019-001056. Epub 2019 Jul 19. J Investig Med. 2020. PMID: 31324695 Free PMC article. Review.
-
Gut Microbiome-based Therapeutics in Liver Cirrhosis: Basic Consideration for the Next Step.J Clin Transl Hepatol. 2017 Sep 28;5(3):249-260. doi: 10.14218/JCTH.2017.00008. Epub 2017 Jun 29. J Clin Transl Hepatol. 2017. PMID: 28936406 Free PMC article. Review.
-
Novel Insights Into Pathogenesis and Therapeutic Strategies of Hepatic Encephalopathy, From the Gut Microbiota Perspective.Front Cell Infect Microbiol. 2021 Feb 22;11:586427. doi: 10.3389/fcimb.2021.586427. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 33692964 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources